LUCD on XNAS, Health Care, Lucid Diagnostics Inc., job postings
Measures activity, not value. Not investment advice.
Short interest hit 12.8M shares, 2.3 times a year earlier, while shares fell 63% in a year.
BadOne delisting notice filed in the last 90 days
BadNet loss of $48.5M over the last 12 months
Written by AI from the data on this page, 22 Nov 2026. Not investment advice.
Profile and fundamentals
From its SEC filings, 12 months to 30 Sep 2026
Lucid Diagnostics Inc is a commercial-stage medical diagnostics technology company focused on the millions of patients with gastroesophageal reflux disease (GERD), also known as chronic heartburn, acid reflux, or simply reflux, who are at risk of developing esophageal precancer and cancer, specifically lethal esophageal adenocarcinoma. Its products include EsoCheck and EsoGuard.
Industry
Surgical & medical instruments & apparatus (Health Care)
expected around 25 Mar 2027 (an estimate: a year ago it reported on 26 Mar 2026)
Revenue and net income per quarter. Quarter to 30 Sep 2026: revenue $1.2M, net loss $6.7M.
31 Dec 2021RevenueNet incomeNet losstallest bar $26.9M30 Sep 2026
See the numbers
Quarter to
Revenue
Net income
30 Sep 2026
$1.2M
-$6.7M
30 Jun 2026
$1.5M
-$11.7M
31 Mar 2026
$1.3M
-$13.9M
31 Dec 2025
$1.5M
-$16.3M
30 Sep 2025
$1.2M
-$10.4M
30 Jun 2025
$1.2M
-$4.4M
31 Mar 2025
$828K
-$26.9M
31 Dec 2024
$1.2M
-$11.5M
30 Sep 2024
$1.2M
-$12.4M
30 Jun 2024
$976K
-$11.0M
31 Mar 2024
$1.0M
-$10.6M
31 Dec 2023
$1.0M
-$10.8M
30 Sep 2023
$783K
-$14.2M
30 Jun 2023
$159K
-$11.4M
31 Mar 2023
$446K
-$16.2M
31 Dec 2022
$112K
-$14.9M
30 Sep 2022
$76K
-$14.3M
30 Jun 2022
–
-$14.6M
31 Mar 2022
$189K
-$12.3M
31 Dec 2021
$300K
-$11.3M
Fundamentals, 12 months to 30 Sep 2026
Measure
Latest
Year before
Peer median
RevenueiSales over the last 12 months reported.
$5.4M
$4.4M
Revenue growthiRevenue of the last 12 months compared with the 12 months before.
+24%
+13%
Net incomeiProfit after all costs and taxes over the last 12 months reported. Negative is a loss.
-$48.5M
-$53.3M
EPS (diluted)iEarnings per share: net income divided by the shares, counting options and convertibles. Left blank when the figures as filed do not fit today's share count (after a split).
–
–
Gross marginiWhat is left of each dollar of sales after the direct cost of making the product or service.
-16.5%
–
60.5%
Operating marginiOperating income as a share of sales: profit from the business before interest and taxes.
-942%
–
-8.3%
Net marginiNet income as a share of sales: what the owners keep of each dollar sold.
-893%
–
-10.1%
Return on equityiNet income of the last 12 months divided by shareholders' equity (the average of the latest balance sheet and the one a year earlier): the profit made on the owners' money.
-306%
-26.3%
Free cash flowiCash from operations minus capital spending over the last 12 months: cash the business produced.
-$51.8M
–
CashiCash, cash equivalents and short-term investments on the latest balance sheet.
$18.0M
$47.3M
DebtiShort- and long-term borrowings on the latest balance sheet. Operating leases are not counted.
$17.3M
$22.3M
Net debtiDebt minus cash. Negative means the company holds more cash than it owes (net cash).
-$693K (net cash)
-$25.0M
Debt to equityiDebt divided by shareholders' equity on the latest balance sheet: how much is borrowed for each dollar the owners have in the company. Blank when equity is negative.
2.9
0.31
Book value per shareiShareholders' equity (assets minus liabilities) on the latest balance sheet divided by the shares outstanding.
$0.03
P/EiPrice to earnings: market cap divided by net income of the last 12 months. What investors pay for one dollar of yearly profit. Blank when the company made a loss.
loss
28.0
P/SiPrice to sales: market cap divided by revenue of the last 12 months.
14.2
2.3
EV/SalesiEnterprise value (market cap plus debt minus cash) divided by revenue of the last 12 months.
14.1
2.5
P/BiPrice to book: market cap divided by shareholders' equity on the latest balance sheet. Blank when equity is negative.
13.0
2.8
Latest = 12 months to 30 Sep 2026; balance-sheet lines at its end. Peer median: companies in the same industry (SIC code), or the sector when the industry is small.
Peers nearest by market cap, its own industry first
Institutional holders iThe number of institutional investment managers (13F filers: funds, pensions, asset managers) reporting the stock, compared with the quarter before. 13F reports are public 45 days after quarter end and show long positions only.
0%
113 13F filers vs 113
Institutional ownership iShares held by 13F filers at the latest quarter end, divided by the shares outstanding in the company's latest filing. Above 100% usually means a stale share count or double counting, and is marked.
29%
60.2M shares held by 13F filers (30 Sep 2026) of 207.0M outstanding (10 Nov 2026)
Short interest iShares sold short and not yet bought back, divided by the shares outstanding in the company's latest filing. From FINRA's latest short interest report: FINRA reports twice a month and publishes 7 business days after the settlement date. Above 100% means a stale share count, and is marked.
7.2%
15.0M shares sold short (30 Oct 2026) of 207.0M outstanding (10 Nov 2026)
Days to cover iShort interest divided by the stock's average daily trading volume, as FINRA publishes it: how many days of normal trading it would take short sellers to buy back every share. Latest report.
1.0
15.0M shares sold short (30 Oct 2026) divided by the stock's average daily volume, as FINRA publishes it
Short interest change iHow the number of shares sold short changed between FINRA's two latest reports, about two weeks apart.
+9.9%
13.6M shares sold short in the report before, 15.0M on 30 Oct 2026
Short sale volume iShare of the stock's latest daily volume on FINRA-reported off-exchange venues that was sold short. Market makers sell short routinely, so 40% to 50% is normal; compare it with the company's own 1-year average in the cell's details. A daily flow, not short interest.
64%
64% of off-exchange volume on 20 Nov 2026 was short sales; 1-year average 57%
News iArticles about the company published in the last 7 days, from our Google News collection (one search per company, every half hour). Blank when we do not collect news for this company.
3
3 articles in the last 7 days; its usual week has 1 (the median of the 26 weeks before).
News vs usual iArticles in the last 7 days divided by the company's usual week: the median week of the 26 weeks before. Blank when the usual week has fewer than one article.
3.0×
3 articles in the last 7 days; its usual week has 1.
Unusual now sharp changes in the last 90 days, compared with its own past
Short interest 12.8M, 2.3× a year earlier
Price $0.37 on 20 Nov 2026, -63% over 12 months (12-month range $0.33 to $1.47)
Sharp change
8-K and other filings
Insider net buying (open market). Insiders bought a net $245K in the last 12 months (the 12 months before: $560K).Revenue per quarter. Revenue $1.2M in the latest quarter, -0.7% on a year earlier.Capital spending per quarter. Capital spending $17K in the latest quarter, -39% on a year earlier.Institutional holders (13F filers). 113 13F filers reported holding it in the latest 13F quarter, +43% on a year earlier.
Every point sits on the day the fact became public (filing acceptance or publication), not the day it happened; prices through 20 Nov 2026. Hover or tap a marker for the fact; click it for the evidence or the source. No data here for: h-1b/e-3 applications certified, federal obligations, lobbying spend, workers in warn layoff notices.
Two or more unrelated kinds of records unusual within 30 days
14 Aug 2025confirmed
Confirmed across sources Institutional holdings and Short interest and volume
Lucid Diagnostics(LUCD): had 4.8M shares sold short in the 15 Jul 2025 report, 6.8× the same report last year, while it saw 31 13F filers open a new position in the quarter ended 30 Jun 2025, 4.4× the same quarter last year. Two unrelated kinds of activity within 77 days.
Short interest and volume: Short interest spike, became public on 25 Jul 2025
Short interest and volume: Short interest spike, became public on 12 Aug 2025
Institutional holdings: Many funds opening a new position, became public on 14 Aug 2025
Short interest and volume: Short interest spike, became public on 27 Aug 2025
Short interest and volume: Short interest spike, became public on 11 Sep 2025
Short interest and volume: Short interest spike, became public on 25 Sep 2025
Short interest and volume: Short interest spike, became public on 10 Oct 2025
The 15 Jul 2025 report against the 24 reports before it.
this reportearliernormal: 752KSee the evidence (7 changes)
Short interest and volume: Short interest spike became public on 25 Jul 2025
Lucid Diagnostics had 4.8M shares sold short in the 15 Jul 2025 report, 6.8× the same report last year.
This period
4.8M (the 15 Jul 2025 report)
Normal report (median of 24 earlier)
752K
Typical spread (median absolute deviation)
333K
How far from its usual level
+8.2
Same report last year
700K
History used
1,355 days
the 15 Jul 2025 report24 earlier reportsnormal: 752K
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.
Short interest and volume: Short interest spike became public on 12 Aug 2025
Lucid Diagnostics had 5.3M shares sold short in the 31 Jul 2025 report, 9.3× the same report last year.
This period
5.3M (the 31 Jul 2025 report)
Normal report (median of 24 earlier)
922K
Typical spread (median absolute deviation)
467K
How far from its usual level
+6.3
Same report last year
568K
History used
1,371 days
the 31 Jul 2025 report24 earlier reportsnormal: 922K
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.
Institutional holdings: Many funds opening a new position became public on 14 Aug 2025
Lucid Diagnostics saw 31 13F filers open a new position in the quarter ended 30 Jun 2025, 4.4× the same quarter last year.
This period
31 (the quarter ended 30 Jun 2025)
Normal quarter (median of 8 earlier)
6.5
Typical spread (median absolute deviation)
3.5
How far from its usual level
+4.7
Same quarter last year
7
History used
1,277 days
the quarter ended 30 Jun 20258 earlier quartersnormal: 6.5
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 6+ earlier periods, 730+ days of history and a value of at least 20.
Short interest and volume: Short interest spike became public on 27 Aug 2025
Lucid Diagnostics had 5.5M shares sold short in the 15 Aug 2025 report, 9.5× the same report last year.
This period
5.5M (the 15 Aug 2025 report)
Normal report (median of 24 earlier)
1.1M
Typical spread (median absolute deviation)
575K
How far from its usual level
+5.2
Same report last year
577K
History used
1,386 days
the 15 Aug 2025 report24 earlier reportsnormal: 1.1M
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.
Short interest and volume: Short interest spike became public on 11 Sep 2025
Lucid Diagnostics had 5.3M shares sold short in the 29 Aug 2025 report, 10× the same report last year.
This period
5.3M (the 29 Aug 2025 report)
Normal report (median of 24 earlier)
1.1M
Typical spread (median absolute deviation)
614K
How far from its usual level
+4.6
Same report last year
507K
History used
1,400 days
the 29 Aug 2025 report24 earlier reportsnormal: 1.1M
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.
Short interest and volume: Short interest spike became public on 25 Sep 2025
Lucid Diagnostics had 6.1M shares sold short in the 15 Sep 2025 report, 17× the same report last year.
This period
6.1M (the 15 Sep 2025 report)
Normal report (median of 24 earlier)
1.2M
Typical spread (median absolute deviation)
634K
How far from its usual level
+5.2
Same report last year
363K
History used
1,417 days
the 15 Sep 2025 report24 earlier reportsnormal: 1.2M
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.
Short interest and volume: Short interest spike became public on 10 Oct 2025
Lucid Diagnostics had 5.3M shares sold short in the 30 Sep 2025 report, 6.6× the same report last year.
This period
5.3M (the 30 Sep 2025 report)
Normal report (median of 24 earlier)
1.3M
Typical spread (median absolute deviation)
740K
How far from its usual level
+3.7
Same report last year
804K
History used
1,432 days
the 30 Sep 2025 report24 earlier reportsnormal: 1.3M
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.
Several things at once means two or more unrelated kinds of records changed sharply within 30 days. Records that come from the same documents (for example filings and the financials taken from them) count as one kind.
Timeline
Changes and notable records, by the date each became public
had 12.8M shares sold short in the 14 Aug 2026 report, 2.3× the same report last year.
Same report last year: 5.5M; its normal report is 5.9M.
See the evidence
This period
12.8M (the 14 Aug 2026 report)
Normal report (median of 24 earlier)
5.9M
Typical spread (median absolute deviation)
1.1M
How far from its usual level
+4.1
Same report last year
5.5M
History used
1,750 days
the 14 Aug 2026 report24 earlier reportsnormal: 5.9M
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.
had 12.1M shares sold short in the 31 Jul 2026 report, 2.3× the same report last year.
Same report last year: 5.3M; its normal report is 5.9M.
See the evidence
This period
12.1M (the 31 Jul 2026 report)
Normal report (median of 24 earlier)
5.9M
Typical spread (median absolute deviation)
990K
How far from its usual level
+4.3
Same report last year
5.3M
History used
1,736 days
the 31 Jul 2026 report24 earlier reportsnormal: 5.9M
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.
had 5.3M shares sold short in the 30 Sep 2025 report, 6.6× the same report last year.
Same report last year: 804K; its normal report is 1.3M.
See the evidence
This period
5.3M (the 30 Sep 2025 report)
Normal report (median of 24 earlier)
1.3M
Typical spread (median absolute deviation)
740K
How far from its usual level
+3.7
Same report last year
804K
History used
1,432 days
the 30 Sep 2025 report24 earlier reportsnormal: 1.3M
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.
had 6.1M shares sold short in the 15 Sep 2025 report, 17× the same report last year.
Same report last year: 363K; its normal report is 1.2M.
See the evidence
This period
6.1M (the 15 Sep 2025 report)
Normal report (median of 24 earlier)
1.2M
Typical spread (median absolute deviation)
634K
How far from its usual level
+5.2
Same report last year
363K
History used
1,417 days
the 15 Sep 2025 report24 earlier reportsnormal: 1.2M
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.
had 5.3M shares sold short in the 29 Aug 2025 report, 10× the same report last year.
Same report last year: 507K; its normal report is 1.1M.
See the evidence
This period
5.3M (the 29 Aug 2025 report)
Normal report (median of 24 earlier)
1.1M
Typical spread (median absolute deviation)
614K
How far from its usual level
+4.6
Same report last year
507K
History used
1,400 days
the 29 Aug 2025 report24 earlier reportsnormal: 1.1M
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.
had 5.5M shares sold short in the 15 Aug 2025 report, 9.5× the same report last year.
Same report last year: 577K; its normal report is 1.1M.
See the evidence
This period
5.5M (the 15 Aug 2025 report)
Normal report (median of 24 earlier)
1.1M
Typical spread (median absolute deviation)
575K
How far from its usual level
+5.2
Same report last year
577K
History used
1,386 days
the 15 Aug 2025 report24 earlier reportsnormal: 1.1M
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.
had 4.8M shares sold short in the 15 Jul 2025 report, 6.8× the same report last year, while it saw 31 13F filers open a new position in the quarter ended 30 Jun 2025, 4.4× the same quarter last year. Two unrelated kinds of activity within 77 days.
See the evidence (7 changes)
Short interest and volume: Short interest spike became public on 25 Jul 2025
Lucid Diagnostics had 4.8M shares sold short in the 15 Jul 2025 report, 6.8× the same report last year.
This period
4.8M (the 15 Jul 2025 report)
Normal report (median of 24 earlier)
752K
Typical spread (median absolute deviation)
333K
How far from its usual level
+8.2
Same report last year
700K
History used
1,355 days
the 15 Jul 2025 report24 earlier reportsnormal: 752K
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.
Short interest and volume: Short interest spike became public on 12 Aug 2025
Lucid Diagnostics had 5.3M shares sold short in the 31 Jul 2025 report, 9.3× the same report last year.
This period
5.3M (the 31 Jul 2025 report)
Normal report (median of 24 earlier)
922K
Typical spread (median absolute deviation)
467K
How far from its usual level
+6.3
Same report last year
568K
History used
1,371 days
the 31 Jul 2025 report24 earlier reportsnormal: 922K
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.
Institutional holdings: Many funds opening a new position became public on 14 Aug 2025
Lucid Diagnostics saw 31 13F filers open a new position in the quarter ended 30 Jun 2025, 4.4× the same quarter last year.
This period
31 (the quarter ended 30 Jun 2025)
Normal quarter (median of 8 earlier)
6.5
Typical spread (median absolute deviation)
3.5
How far from its usual level
+4.7
Same quarter last year
7
History used
1,277 days
the quarter ended 30 Jun 20258 earlier quartersnormal: 6.5
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 6+ earlier periods, 730+ days of history and a value of at least 20.
Short interest and volume: Short interest spike became public on 27 Aug 2025
Lucid Diagnostics had 5.5M shares sold short in the 15 Aug 2025 report, 9.5× the same report last year.
This period
5.5M (the 15 Aug 2025 report)
Normal report (median of 24 earlier)
1.1M
Typical spread (median absolute deviation)
575K
How far from its usual level
+5.2
Same report last year
577K
History used
1,386 days
the 15 Aug 2025 report24 earlier reportsnormal: 1.1M
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.
Short interest and volume: Short interest spike became public on 11 Sep 2025
Lucid Diagnostics had 5.3M shares sold short in the 29 Aug 2025 report, 10× the same report last year.
This period
5.3M (the 29 Aug 2025 report)
Normal report (median of 24 earlier)
1.1M
Typical spread (median absolute deviation)
614K
How far from its usual level
+4.6
Same report last year
507K
History used
1,400 days
the 29 Aug 2025 report24 earlier reportsnormal: 1.1M
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.
Short interest and volume: Short interest spike became public on 25 Sep 2025
Lucid Diagnostics had 6.1M shares sold short in the 15 Sep 2025 report, 17× the same report last year.
This period
6.1M (the 15 Sep 2025 report)
Normal report (median of 24 earlier)
1.2M
Typical spread (median absolute deviation)
634K
How far from its usual level
+5.2
Same report last year
363K
History used
1,417 days
the 15 Sep 2025 report24 earlier reportsnormal: 1.2M
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.
Short interest and volume: Short interest spike became public on 10 Oct 2025
Lucid Diagnostics had 5.3M shares sold short in the 30 Sep 2025 report, 6.6× the same report last year.
This period
5.3M (the 30 Sep 2025 report)
Normal report (median of 24 earlier)
1.3M
Typical spread (median absolute deviation)
740K
How far from its usual level
+3.7
Same report last year
804K
History used
1,432 days
the 30 Sep 2025 report24 earlier reportsnormal: 1.3M
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.
Several things at once means two or more unrelated kinds of records changed sharply within 30 days. Records that come from the same documents (for example filings and the financials taken from them) count as one kind.
14 Aug 2025Institutional holdings change
saw 31 13F filers open a new position in the quarter ended 30 Jun 2025, 4.4× the same quarter last year.
Same quarter last year: 7; its normal quarter is 6.5.
See the evidence
This period
31 (the quarter ended 30 Jun 2025)
Normal quarter (median of 8 earlier)
6.5
Typical spread (median absolute deviation)
3.5
How far from its usual level
+4.7
Same quarter last year
7
History used
1,277 days
the quarter ended 30 Jun 20258 earlier quartersnormal: 6.5
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 6+ earlier periods, 730+ days of history and a value of at least 20.
had 5.3M shares sold short in the 31 Jul 2025 report, 9.3× the same report last year.
Same report last year: 568K; its normal report is 922K.
See the evidence
This period
5.3M (the 31 Jul 2025 report)
Normal report (median of 24 earlier)
922K
Typical spread (median absolute deviation)
467K
How far from its usual level
+6.3
Same report last year
568K
History used
1,371 days
the 31 Jul 2025 report24 earlier reportsnormal: 922K
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.
had 4.8M shares sold short in the 15 Jul 2025 report, 6.8× the same report last year.
Same report last year: 700K; its normal report is 752K.
See the evidence
This period
4.8M (the 15 Jul 2025 report)
Normal report (median of 24 earlier)
752K
Typical spread (median absolute deviation)
333K
How far from its usual level
+8.2
Same report last year
700K
History used
1,355 days
the 15 Jul 2025 report24 earlier reportsnormal: 752K
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.
had 1.8M shares sold short in the 15 May 2025 report, 6.2× the same report last year.
Same report last year: 285K; its normal report is 573K.
See the evidence
This period
1.8M (the 15 May 2025 report)
Normal report (median of 24 earlier)
573K
Typical spread (median absolute deviation)
221K
How far from its usual level
+3.7
Same report last year
285K
History used
1,294 days
the 15 May 2025 report24 earlier reportsnormal: 573K
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.
had 1.6M shares sold short in the 15 Apr 2025 report, 4.4× the same report last year.
Same report last year: 361K; its normal report is 537K.
See the evidence
This period
1.6M (the 15 Apr 2025 report)
Normal report (median of 24 earlier)
537K
Typical spread (median absolute deviation)
175K
How far from its usual level
+4.1
Same report last year
361K
History used
1,264 days
the 15 Apr 2025 report24 earlier reportsnormal: 537K
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.
had 1.4M shares sold short in the 31 Mar 2025 report, 3.1× the same report last year.
Same report last year: 441K; its normal report is 520K.
See the evidence
This period
1.4M (the 31 Mar 2025 report)
Normal report (median of 24 earlier)
520K
Typical spread (median absolute deviation)
157K
How far from its usual level
+3.6
Same report last year
441K
History used
1,249 days
the 31 Mar 2025 report24 earlier reportsnormal: 520K
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.
had 1.2M shares sold short in the 14 Mar 2025 report, 5.3× the same report last year.
Same report last year: 231K; its normal report is 482K.
See the evidence
This period
1.2M (the 14 Mar 2025 report)
Normal report (median of 24 earlier)
482K
Typical spread (median absolute deviation)
119K
How far from its usual level
+4.2
Same report last year
231K
History used
1,232 days
the 14 Mar 2025 report24 earlier reportsnormal: 482K
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.
had 1.8M shares sold short in the 28 Feb 2025 report, 8.8× the same report last year.
Same report last year: 203K; its normal report is 449K.
See the evidence
This period
1.8M (the 28 Feb 2025 report)
Normal report (median of 24 earlier)
449K
Typical spread (median absolute deviation)
118K
How far from its usual level
+7.7
Same report last year
203K
History used
1,218 days
the 28 Feb 2025 report24 earlier reportsnormal: 449K
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.
had 577K shares sold short in the 15 Aug 2024 report, 5.6× the same report last year.
Same report last year: 102K; its normal report is 172K.
See the evidence
This period
577K (the 15 Aug 2024 report)
Normal report (median of 24 earlier)
172K
Typical spread (median absolute deviation)
73K
How far from its usual level
+3.8
Same report last year
102K
History used
1,021 days
the 15 Aug 2024 report24 earlier reportsnormal: 172K
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.
had 568K shares sold short in the 31 Jul 2024 report, 4.8× the same report last year.
Same report last year: 117K; its normal report is 143K.
See the evidence
This period
568K (the 31 Jul 2024 report)
Normal report (median of 24 earlier)
143K
Typical spread (median absolute deviation)
45K
How far from its usual level
+6.4
Same report last year
117K
History used
1,006 days
the 31 Jul 2024 report24 earlier reportsnormal: 143K
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.
had 700K shares sold short in the 15 Jul 2024 report, 5.9× the same report last year.
Same report last year: 119K; its normal report is 123K.
See the evidence
This period
700K (the 15 Jul 2024 report)
Normal report (median of 24 earlier)
123K
Typical spread (median absolute deviation)
31K
How far from its usual level
+11.5
Same report last year
119K
History used
990 days
the 15 Jul 2024 report24 earlier reportsnormal: 123K
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.
had 755K shares sold short in the 28 Jun 2024 report, 5.0× the same report last year.
Same report last year: 150K; its normal report is 123K.
See the evidence
This period
755K (the 28 Jun 2024 report)
Normal report (median of 24 earlier)
123K
Typical spread (median absolute deviation)
27K
How far from its usual level
+12.6
Same report last year
150K
History used
973 days
the 28 Jun 2024 report24 earlier reportsnormal: 123K
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.
had 594K shares sold short in the 14 Jun 2024 report, 4.2× the same report last year.
Same report last year: 142K; its normal report is 123K.
See the evidence
This period
594K (the 14 Jun 2024 report)
Normal report (median of 24 earlier)
123K
Typical spread (median absolute deviation)
25K
How far from its usual level
+9.4
Same report last year
142K
History used
959 days
the 14 Jun 2024 report24 earlier reportsnormal: 123K
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.
Showing the newest 40 of 58 entries; narrow the window or the kind of data to see older ones.
Not listed: 64 routine records (quarterly and annual reports, results releases, other 8-K items, material agreements and individual insider sales), counted over all history.
Identifiers and sources
How records are matched to this company, and what each source holds for it
Cik
0001799011
Ticker
LUCD
Domain
luciddx.com
Hq location
NY|NEW YORK|10017 (1 unverified)
Name
CapNostics LLC (84-4876240), Lucid Diagnostics Inc., LucidDx Labs Inc. (87-41661458), Wholly-Owned Subsidiary of Lucid Diagnostics Inc
SEC Form 13F institutional holdings180 data points31 Dec 2021 to 30 Sep 2026
SEC EDGAR filings (8-K items, S-1, Form D, 10-K/10-Q)88 records22 Sep 2021 to 12 Nov 2026
SEC XBRL company facts (revenue, capex, R&D, backlog...)360 data points31 Dec 2019 to 10 Nov 2026
SEC Form 4 insider transactions9 records, 28 data points20 Oct 2021 to 21 May 2026
FINRA short interest (twice monthly)359 data points29 Oct 2021 to 30 Oct 2026
FINRA daily short sale volume (off-exchange)2564 data points14 Oct 2021 to 20 Nov 2026